{"transactions":[{"id":689919,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-12T19:23:26.000Z","date":"2026-08-11","kind":"grant","planned":false,"acquired":true,"shares":11149,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the \"Plan\") and vests one-third on each of the three anniversaries of the grant date."}],"balance_after":43077,"source":{"system":"sec-edgar","filing":"0001193125-26-346678","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876427/000119312526346678/ownership.xml","form_type":"4"}},{"id":1068257,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2025-08-13T17:37:02.000Z","date":"2025-08-12","kind":"grant","planned":true,"acquired":true,"shares":8306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the \"Plan\") and vests one-third on each of the three anniversaries of the grant date."}],"balance_after":31928,"source":{"system":"sec-edgar","filing":"0000950170-25-107826","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876427/000095017025107826/ownership.xml","form_type":"4"}},{"id":1432996,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2024-08-15T19:46:18.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":4937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock is granted under the Company's Amended and Restated 2007 Stock Incentive Plan (the \"Plan\") and vests one-third on each of the three anniversaries of the grant date."}],"balance_after":23622,"source":{"system":"sec-edgar","filing":"0000950170-24-097535","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876427/000095017024097535/ownership.xml","form_type":"4"}},{"id":1650398,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":19597,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":17.72,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":19597},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650397,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":3.37,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650396,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":44000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":6.77,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650395,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":4.56,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650394,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":2.1,"expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650393,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":18000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":11.21,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650392,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":4.64,"expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650391,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":1.84,"expiration_date":"2026-12-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650390,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":13.07,"expiration_date":"2025-11-10","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650389,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such Stock Option, an amount in cash (less any applicable withholding taxes) equal to (i) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of the Merger Consideration over the applicable exercise price per share of Common Stock under such Stock Option."}],"balance_after":0,"derivative":{"exercise_price":10.1,"expiration_date":"2024-11-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650388,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Unit","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":105458,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each deferred share unit (\"DSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such DSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of Common Stock subject to such DSU immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each deferred share unit (\"DSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such DSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of Common Stock subject to such DSU immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each deferred share unit (\"DSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such DSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of Common Stock subject to such DSU immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each deferred share unit (\"DSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such DSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of Common Stock subject to such DSU immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each deferred share unit (\"DSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such DSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of Common Stock subject to such DSU immediately prior to the Effective Time, multiplied by (ii) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":105458},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1650387,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-12T16:40:17.000Z","date":"2024-02-12","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":13090,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 30, 2023, by and among the Issuer, AbbVie Inc., a Delaware corporation (\"AbbVie\"), Athene Subsidiary LLC, a Delaware limited liability company and wholly owned subsidiary of AbbVie (\"Intermediate Sub\"), and Athene Merger Sub Inc., a Massachusetts corporation and wholly owned subsidiary of Intermediate Sub (\"Purchaser\"), pursuant to which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation (the \"Merger\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each restricted stock unit (\"RSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such RSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of common stock, par value $.01 per share, of the Issuer (\"Common Stock\") subject to such RSU immediately prior to the Effective Time, multiplied by (ii) $31.26, without interest (the \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 30, 2023, by and among the Issuer, AbbVie Inc., a Delaware corporation (\"AbbVie\"), Athene Subsidiary LLC, a Delaware limited liability company and wholly owned subsidiary of AbbVie (\"Intermediate Sub\"), and Athene Merger Sub Inc., a Massachusetts corporation and wholly owned subsidiary of Intermediate Sub (\"Purchaser\"), pursuant to which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation (the \"Merger\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each restricted stock unit (\"RSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such RSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of common stock, par value $.01 per share, of the Issuer (\"Common Stock\") subject to such RSU immediately prior to the Effective Time, multiplied by (ii) $31.26, without interest (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 30, 2023, by and among the Issuer, AbbVie Inc., a Delaware corporation (\"AbbVie\"), Athene Subsidiary LLC, a Delaware limited liability company and wholly owned subsidiary of AbbVie (\"Intermediate Sub\"), and Athene Merger Sub Inc., a Massachusetts corporation and wholly owned subsidiary of Intermediate Sub (\"Purchaser\"), pursuant to which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each restricted stock unit (\"RSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such RSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of common stock, par value $.01 per share, of the Issuer (\"Common Stock\") subject to such RSU immediately prior to the Effective Time, multiplied by (ii) $31.26, without interest (the \"Merger Consideration\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 30, 2023, by and among the Issuer, AbbVie Inc., a Delaware corporation (\"AbbVie\"), Athene Subsidiary LLC, a Delaware limited liability company and wholly owned subsidiary of AbbVie (\"Intermediate Sub\"), and Athene Merger Sub Inc., a Massachusetts corporation and wholly owned subsidiary of Intermediate Sub (\"Purchaser\"), pursuant to which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation (the \"Merger\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each restricted stock unit (\"RSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such RSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of common stock, par value $.01 per share, of the Issuer (\"Common Stock\") subject to such RSU immediately prior to the Effective Time, multiplied by (ii) $31.26, without interest (the \"Merger Consideration\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated November 30, 2023, by and among the Issuer, AbbVie Inc., a Delaware corporation (\"AbbVie\"), Athene Subsidiary LLC, a Delaware limited liability company and wholly owned subsidiary of AbbVie (\"Intermediate Sub\"), and Athene Merger Sub Inc., a Massachusetts corporation and wholly owned subsidiary of Intermediate Sub (\"Purchaser\"), pursuant to which Purchaser merged with and into the Issuer with the Issuer continuing as the surviving corporation (the \"Merger\")."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), each restricted stock unit (\"RSU\") granted prior to the date of the Merger Agreement that was outstanding immediately prior to the Effective Time was canceled, and the Reporting Person was entitled to receive (without interest), in consideration of the cancellation of such RSU, an amount in cash (less any applicable withholding taxes) equal to (i) the number of shares of common stock, par value $.01 per share, of the Issuer (\"Common Stock\") subject to such RSU immediately prior to the Effective Time, multiplied by (ii) $31.26, without interest (the \"Merger Consideration\")."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13090},"source":{"system":"sec-edgar","filing":"0001104659-24-014704","document":"tm245865-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000110465924014704/tm245865-6_4seq1.xml","form_type":"4"}},{"id":1781456,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-14T17:30:38.000Z","date":"2023-09-13","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effected pursuant to a trading plan adopted on June 14, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on 11/12/2013 and is fully vested as of the transaction date."}],"balance_after":0,"derivative":{"exercise_price":14.7,"expiration_date":"2023-11-12","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-23-013291","document":"form4-09142023_090923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923013291/form4-09142023_090923.xml","form_type":"4"}},{"id":1781455,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-14T17:30:38.000Z","date":"2023-09-13","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":16.05,"value":160500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effected pursuant to a trading plan adopted on June 14, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.90 to $16.10, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-013291","document":"form4-09142023_090923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923013291/form4-09142023_090923.xml","form_type":"4"}},{"id":1781454,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-14T17:30:38.000Z","date":"2023-09-13","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":14.7,"value":147000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Effected pursuant to a trading plan adopted on June 14, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-23-013291","document":"form4-09142023_090923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923013291/form4-09142023_090923.xml","form_type":"4"}},{"id":1804596,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Awards","published_at":"2023-08-17T12:22:00.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":3749,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":18685,"source":{"system":"sec-edgar","filing":"0001209191-23-046178","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919123046178/doc4.xml","form_type":"4"}},{"id":1853416,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T16:48:38.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":19597,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The stock options were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors, as amended, and the 2018 Employee, Director and Consultant Equity Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options vest ratably on each of 9/1/23, 12/1/23, 3/1/24, and 6/1/24, contingent upon the individual remaining a director as of each vesting date."}],"balance_after":19597,"derivative":{"exercise_price":17.72,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":19597},"source":{"system":"sec-edgar","filing":"0001415889-23-009951","document":"form4-06162023_080628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923009951/form4-06162023_080628.xml","form_type":"4"}},{"id":1853415,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-16T16:48:38.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":13090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units (\"RSUs\") were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors, as amended, and the 2018 Employee, Director and Consultant Equity Incentive Plan, as amended. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units (\"RSUs\") were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors, as amended, and the 2018 Employee, Director and Consultant Equity Incentive Plan, as amended. Each RSU represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, contingent upon the individual remaining a director as of the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on the one-year anniversary of the date of grant, contingent upon the individual remaining a director as of the vesting date."}],"balance_after":13090,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":13090},"source":{"system":"sec-edgar","filing":"0001415889-23-009951","document":"form4-06162023_080628.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588923009951/form4-06162023_080628.xml","form_type":"4"}},{"id":2180202,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Awards","published_at":"2022-08-18T17:55:41.000Z","date":"2022-08-16","kind":"grant","acquired":true,"shares":2426,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14936,"source":{"system":"sec-edgar","filing":"0001209191-22-046562","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919122046562/doc4.xml","form_type":"4"}},{"id":2228954,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T16:16:03.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":44000,"price":3.37,"value":148280.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 11,000 shares on each of 9/1/22, 12/1/22, 3/1/23, and 6/1/23, contingent upon the individual remaining a director as of each vesting date."}],"balance_after":44000,"derivative":{"exercise_price":3.37,"expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001415889-22-006727","document":"form4-06172022_010645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588922006727/form4-06172022_010645.xml","form_type":"4"}},{"id":2228953,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Unit","published_at":"2022-06-17T16:16:03.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The deferred share units vest ratably over a one-year period in quarterly increments beginning on 9/1/22, contingent upon the individual remaining a director as of each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."}],"balance_after":105458,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-22-006727","document":"form4-06172022_010645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000141588922006727/form4-06172022_010645.xml","form_type":"4"}},{"id":2596723,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2021-08-19T18:40:22.000Z","date":"2021-08-17","kind":"grant","acquired":true,"shares":2351,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12510,"source":{"system":"sec-edgar","filing":"0001209191-21-052487","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919121052487/doc4.xml","form_type":"4"}},{"id":2609189,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2021-08-10T20:25:40.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":10000,"price":57.78,"value":577800.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":57.78,"exercise_date":"2017-08-09","expiration_date":"2021-08-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-050609","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919121050609/doc4.xml","form_type":"4"}},{"id":2609188,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T20:25:40.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":10000,"price":58.6528,"value":586528.0,"ownership":{"direct":true},"balance_after":10159,"source":{"system":"sec-edgar","filing":"0001209191-21-050609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919121050609/doc4.xml","form_type":"4"}},{"id":2609187,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-10T20:25:40.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":10000,"price":57.78,"value":577800.0,"ownership":{"direct":true},"balance_after":20159,"source":{"system":"sec-edgar","filing":"0001209191-21-050609","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919121050609/doc4.xml","form_type":"4"}},{"id":2664985,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T16:25:05.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":44000,"price":6.77,"value":297880.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 11,000 shares on each of 9/1/21, 12/1/21, 3/1/22, and 6/1/22, contingent upon the individual remaining a director as of each vesting date."}],"balance_after":44000,"derivative":{"exercise_price":6.77,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001179110-21-006819","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911021006819/edgar.xml","form_type":"4"}},{"id":2664984,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Unit","published_at":"2021-06-17T16:25:05.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The deferred share units vest quarterly on each of 9/1/21, 12/1/21, 3/1/22, and 6/1/22, contingent upon the individual remaining a director as of each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."}],"balance_after":90458,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001179110-21-006819","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911021006819/edgar.xml","form_type":"4"}},{"id":3051592,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Awards","published_at":"2020-08-20T15:37:13.000Z","date":"2020-08-18","kind":"grant","acquired":true,"shares":2575,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10159,"source":{"system":"sec-edgar","filing":"0001209191-20-047684","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919120047684/doc4.xml","form_type":"4"}},{"id":3106011,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T16:08:53.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":50000,"price":4.56,"value":228000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 12,500 shares on each of 9/1/20, 12/1/20, 3/1/21 and 6/1/21, contingent upon the individual remaining a director as of each vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.56,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001179110-20-007532","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911020007532/edgar.xml","form_type":"4"}},{"id":3106010,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Unit","published_at":"2020-06-18T16:08:53.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":17000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The deferred share units vest quarterly on each of 9/1/20, 12/1/20, 3/1/21 and 6/1/21, contingent upon the individual remaining a director as of each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."}],"balance_after":75458,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":17000},"source":{"system":"sec-edgar","filing":"0001179110-20-007532","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911020007532/edgar.xml","form_type":"4"}},{"id":3438029,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Awards","published_at":"2019-08-15T16:11:53.000Z","date":"2019-08-13","kind":"grant","acquired":true,"shares":1661,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7584,"source":{"system":"sec-edgar","filing":"0001209191-19-046047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919119046047/doc4.xml","form_type":"4"}},{"id":3480619,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-24T10:25:48.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":18000,"price":2.1,"value":37800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 4,500 shares on 9/1/19, 12/1/19, 3/1/20 and 6/1/20, contingent upon the individual remaining a director as of each vesting date."}],"balance_after":18000,"derivative":{"exercise_price":2.1,"exercise_date":"2019-09-01","expiration_date":"2029-06-20","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001179110-19-008043","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911019008043/edgar.xml","form_type":"4"}},{"id":3480618,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Unit","published_at":"2019-06-24T10:25:48.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The deferred share units vest quarterly on 9/1/19, 12/1/19, 3/1/20 and 6/1/20, contingent upon the individual remaining a director as of each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."}],"balance_after":58458,"derivative":{"exercise_price":0,"exercise_date":"2019-09-01","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001179110-19-008043","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911019008043/edgar.xml","form_type":"4"}},{"id":3651471,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2019-02-19T17:28:04.000Z","date":"2019-02-14","kind":"exercise","acquired":false,"shares":10000,"price":51.51,"value":515100.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":51.51,"exercise_date":"2014-08-05","expiration_date":"2019-08-05","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-010928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919119010928/doc4.xml","form_type":"4"}},{"id":3651470,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T17:28:04.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":100,"price":80.338,"value":8033.8,"ownership":{"direct":true},"balance_after":5923,"source":{"system":"sec-edgar","filing":"0001209191-19-010928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919119010928/doc4.xml","form_type":"4"}},{"id":3651469,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T17:28:04.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":2000,"price":78.6806,"value":157361.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price.  these shares were sold in multiple transactions at prices ranging from $78.26 to $78.93, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold."}],"balance_after":6023,"source":{"system":"sec-edgar","filing":"0001209191-19-010928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919119010928/doc4.xml","form_type":"4"}},{"id":3651468,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T17:28:04.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":4600,"price":77.7027,"value":357432.42,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  these shares were sold in multiple transactions at prices ranging from $77.28 to $78.22, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold."}],"balance_after":8023,"source":{"system":"sec-edgar","filing":"0001209191-19-010928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919119010928/doc4.xml","form_type":"4"}},{"id":3651467,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T17:28:04.000Z","date":"2019-02-14","kind":"sale","acquired":false,"shares":3300,"price":76.7606,"value":253309.98,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price.  these shares were sold in multiple transactions at prices ranging from $76.25 to $77.24, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold."}],"balance_after":12623,"source":{"system":"sec-edgar","filing":"0001209191-19-010928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919119010928/doc4.xml","form_type":"4"}},{"id":3651466,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-02-19T17:28:04.000Z","date":"2019-02-14","kind":"exercise","acquired":true,"shares":10000,"price":51.51,"value":515100.0,"ownership":{"direct":true},"balance_after":15923,"source":{"system":"sec-edgar","filing":"0001209191-19-010928","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919119010928/doc4.xml","form_type":"4"}},{"id":3842570,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Award","published_at":"2018-08-16T17:57:02.000Z","date":"2018-08-14","kind":"grant","acquired":true,"shares":1828,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5923,"source":{"system":"sec-edgar","filing":"0001209191-18-046966","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919118046966/doc4.xml","form_type":"4"}},{"id":3885645,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-22T14:07:01.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":18000,"price":11.21,"value":201780.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 4,500 shares on 9/1/18, 12/1/18, 3/1/19 and 6/1/19, contingent upon the individual remaining a director as of each vesting date."}],"balance_after":18000,"derivative":{"exercise_price":11.21,"exercise_date":"2018-09-01","expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001179110-18-008933","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018008933/edgar.xml","form_type":"4"}},{"id":3885644,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Unit","published_at":"2018-06-22T14:07:01.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The deferred share units vest quarterly on 9/1/18, 12/1/18, 3/1/19 and 6/1/19, contingent upon the individual remaining a director as of each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."}],"balance_after":54458,"derivative":{"exercise_price":0,"exercise_date":"2018-09-01","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001179110-18-008933","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911018008933/edgar.xml","form_type":"4"}},{"id":4077563,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options (Right to Buy)","published_at":"2018-02-05T21:09:42.000Z","date":"2018-02-05","kind":"exercise","acquired":false,"shares":10000,"price":44.46,"value":444600.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":44.46,"exercise_date":"2013-08-06","expiration_date":"2018-08-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-007428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919118007428/doc4.xml","form_type":"4"}},{"id":4077562,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-05T21:09:42.000Z","date":"2018-02-05","kind":"sale","acquired":false,"shares":10000,"price":55.51,"value":555100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $55.00 to $55.90, inclusive.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the \"SEC\"), upon request, full information regarding the number of shares sold."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,895 shares of restricted stock, originally granted on August 15, 2017, which vest according to the following schedule: (i) 965 shares vest on August 15, 2018, (ii) 965 shares vest on August 15, 2019, and (iii) the final 965 shares vest on August 15, 2020."}],"balance_after":4095,"source":{"system":"sec-edgar","filing":"0001209191-18-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919118007428/doc4.xml","form_type":"4"}},{"id":4077561,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-02-05T21:09:42.000Z","date":"2018-02-05","kind":"exercise","acquired":true,"shares":10000,"price":44.46,"value":444600.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,895 shares of restricted stock, originally granted on August 15, 2017, which vest according to the following schedule: (i) 965 shares vest on August 15, 2018, (ii) 965 shares vest on August 15, 2019, and (iii) the final 965 shares vest on August 15, 2020."}],"balance_after":14095,"source":{"system":"sec-edgar","filing":"0001209191-18-007428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000120919118007428/doc4.xml","form_type":"4"}},{"id":4233159,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Awards","published_at":"2017-08-16T19:22:36.000Z","date":"2017-08-15","kind":"grant","acquired":true,"shares":2895,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4095,"source":{"system":"sec-edgar","filing":"0000899243-17-020468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000089924317020468/doc4.xml","form_type":"4"}},{"id":4251429,"issuer":{"id":5682,"kind":"organization","name":"MONRO, INC."},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-26T18:02:04.000Z","date":"2017-07-25","kind":"purchase","acquired":true,"shares":1200,"price":46.4468,"value":55736.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $46.35 to $46.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0000899243-17-018957","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876427/000089924317018957/doc4.xml","form_type":"4"}},{"id":4281571,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-15T10:00:12.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":10000,"price":4.64,"value":46400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 2,500 shares on 9/1/17, 12/1/17, 3/1/18 and 6/1/18, contingent upon the individual remaining a director as of each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":4.64,"exercise_date":"2017-09-01","expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-17-009092","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911017009092/edgar.xml","form_type":"4"}},{"id":4281570,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Unit","published_at":"2017-06-15T10:00:12.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The deferred share units vest quarterly on 9/1/17, 12/1/17, 3/1/18 and 6/1/18, contingent upon the individual remaining a director as of each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."}],"balance_after":50458,"derivative":{"exercise_price":0,"exercise_date":"2017-09-01","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001179110-17-009092","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911017009092/edgar.xml","form_type":"4"}},{"id":4524608,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-12-13T10:57:36.000Z","date":"2016-12-09","kind":"grant","acquired":true,"shares":5000,"price":1.84,"value":9200.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Exercisable as to 2,500 shares commencing on March 1, 2017 and 2,500 shares commencing on June 1, 2017, contingent upon the individual remaining a director as of each vesting date."}],"balance_after":5000,"derivative":{"exercise_price":1.84,"exercise_date":"2017-03-01","expiration_date":"2026-12-09","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001179110-16-032854","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911016032854/edgar.xml","form_type":"4"}},{"id":4524607,"issuer":{"id":94428,"kind":"organization","name":"ImmunoGen, Inc.","symbol":"IMGN"},"owners":[{"id":24346,"kind":"person","name":"MCCLUSKI STEPHEN C","position":1,"cik":"0001188728","reported_name":"MCCLUSKI STEPHEN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Deferred Share Unit","published_at":"2016-12-13T10:57:36.000Z","date":"2016-12-09","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The deferred share units vest one-half on March 1, 2017 and one-half on June 1, 2017, contingent upon the individual remaining a director as of each vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors."}],"balance_after":47458,"derivative":{"exercise_price":0,"exercise_date":"2017-03-01","underlying":"Common Stock","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001179110-16-032854","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/855654/000117911016032854/edgar.xml","form_type":"4"}}]}